CTX-343, a Selective, Potent, Peripherally Restricted LPA Receptor 1 (LPAR1) Antagonist for Treating MASH and Other Fibrotic Liver Diseases
Authors – D. Bagnol, J.S. Swaney, D.S. Lorrain, K.I. Lorrain, A.R. Broadhead, C.Baccei, L. Eide, B. Paulson, G. Edu, J. Atkins, K.J. Stebbins, M.M. Poon, A. Chen
Date – November 7, 2026
Presented at AASLD 2026